Biogelx are helping researchers working in translational science, drug discovery and tissue engineering to “model in vivo conditions in vitro”. We do this through designing and supplying synthetic hydrogels for 3D cell culture and bioprinting. Our products are reproducible and scalable, meaning they are suitable for fundamental research right through to pharmaceutical decision making.
Printing with Biogelx™-Ink-S.
3D bioprinting can be used to print a range of 3D culture systems and human tissue models to produce better in vitro testing by generating models with improved physiological relevance. If you have a preferred BiogelxTM Hydrogel formulation but want to develop a more advanced 3D model using bioprinting, we are here to support you. BiogelxTM-INKs are based on our core products, which enable us to make your preferred formulation printable over a short timescale. With our formulation development, we can offer you a bioink with excellent printability and biocompatibility for your desired cell type and application.
We understand that cells just like humans have individual characteristics. Thus, each cell type needs tailored cell culture products and treatment to better mimic their natural life cycle and response to diseases and drugs in a laboratory environment. To de-risk your purchase and supply you with the best cell culture product on the market, we have designed a BiogelxTM Screening Kit. The kit contains all of the BiogelxTM Hydrogel formulations currently available. We also provide you with different preparation guidelines and live technical support to help you to find the best gel stiffness and chemical functionality for your cell line.
Biogelx was born in academic labs. We believe universities – as knowledge centers, nurturing a new generation of scientists – have the greatest chance of developing novel models and innovative tissue engineering techniques. It is these discoveries that will provide pharmaceutical and healthcare organizations with better analytical tools and new treatments to advance the future of medicine. This belief has resulted in Biogelx’s strong collaboration culture.
We have a proven track record of working effectively with research groups across the UK, Europe, and the US, helping them achieve their research goals with our hydrogel technology. We have supported projects in a range of innovative biomedical applications from using the stiffness tuning aspect of our materials to control stem cell fate, to the development of novel spinal cord injury treatments, where our materials provide an encouraging environment for spinal nerves to regrow.
From 20 to 21 January BiogelxTM attended the joint IBIN/3DbioNet meeting in London where Africa Galvez-Flores (Marie Sklodowska-Curie Researcher) and […]
Our webinar entitled “The Use of 3D Bioprinting to Achieve Uniformity and Reproducibility of In Vitro Skin Models” has concluded. […]
It is with great sadness that Biogelx announce the retirement of our former Chief Executive Officer, Mitch Scanlan. We would […]